RELEASE 01 · SUBLINGUAL BROMANTANE DROPS
NeuroDrive
Dopamine synthesis support. Without the stimulant architecture.
30 ml · 80 mg/ml · ~30 day supply
Supply
$120
$120 / bottle
The mechanism
One restores your baseline. The other borrows from it.
NEURODRIVE — SYNTHESIS-LED
Bromantane upregulates tyrosine hydroxylase — the rate-limiting enzyme in dopamine synthesis. More of your own dopamine, built on your own rhythm. The effect doesn't peak and drop.
STIMULANTS — RELEASE-LED
Forces existing dopamine reserves into the synapse faster. Feels strong. Ends in a crash — and the next dose has less to work with than the last.
Formula
Exactly what’s in the bottle.
Composition
Sublingual protocol
No spike, no crash
Synthesis-based upregulation builds toward a stable ceiling. Your output at hour six looks like your output at hour one.
No tolerance buildup
Bromantane does not downregulate its own pathway. The effect doesn't require escalating doses to maintain.
Sublingual delivery
Under-tongue absorption bypasses first-pass liver metabolism. Faster onset, less compound lost in transit.
BATCH 01 · QUALITY VERIFICATION
Verifiable by design.
Every batch is characterised by ¹H and ¹³C NMR spectroscopy. The raw FID files are published below — process them yourself in MestReNova, TopSpin, or any compatible NMR software.
¹H NMR
400 MHz · CDCl₃
¹³C NMR
100 MHz · CDCl₃
Raw FID data
Original spectrometer output. Compatible with MestReNova, TopSpin, and standard NMR software.
Common questions